Cite
Spielmans GI, Berman MI, Linardatos E, et al. Adjunctive Atypical Antipsychotic Treatment for Major Depressive Disorder: A Meta-Analysis of Depression, Quality of Life, and Safety Outcomes. Focus (Am Psychiatr Publ). 2016;14(2):244-265doi: 10.1176/appi.focus.140202.
Spielmans, G. I., Berman, M. I., Linardatos, E., Rosenlicht, N. Z., Perry, A., & Tsai, A. C. (2016). Adjunctive Atypical Antipsychotic Treatment for Major Depressive Disorder: A Meta-Analysis of Depression, Quality of Life, and Safety Outcomes. Focus (American Psychiatric Publishing), 14(2), 244-265. https://doi.org/10.1176/appi.focus.140202
Spielmans, Glen I, et al. "Adjunctive Atypical Antipsychotic Treatment for Major Depressive Disorder: A Meta-Analysis of Depression, Quality of Life, and Safety Outcomes." Focus (American Psychiatric Publishing) vol. 14,2 (2016): 244-265. doi: https://doi.org/10.1176/appi.focus.140202
Spielmans GI, Berman MI, Linardatos E, Rosenlicht NZ, Perry A, Tsai AC. Adjunctive Atypical Antipsychotic Treatment for Major Depressive Disorder: A Meta-Analysis of Depression, Quality of Life, and Safety Outcomes. Focus (Am Psychiatr Publ). 2016 Apr;14(2):244-265. doi: 10.1176/appi.focus.140202. Epub 2016 Apr 07. PMID: 31997952; PMCID: PMC6519642.
Copy
Download .nbib